Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 00:33:07 - browse：84888

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： H5N1 bird flu: what we're starting to learn about infection in cows

WSS

Roche drug slashes death risk in early

UnitedHealth, Optum discontinue NaviHealth name

Smaller biotechs seek to piggyback on weight loss drug boom

Readout LOUD podcast: Live from the 2023 STAT Summit

Elevance, private equity launch primary care company

Study: People of West African ancestry at greater risk of cardiac amyloidosis

explore

Wikipedia

hotspot

Medicare details structure of new drug price negotiation program

STAT Summit: The economic case for universal basic health care

In age of alternative facts, a scholarly course on calling out crap

FDA clears Verve to begin U.S. study of gene

How to save PrEP access — and even expand it

Study: AI not yet building 'n

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Roivant's CEO is a star, but biotech's black hole persists

Trump demands the U.S. pay no more for drugs than other countries … again

Google says AlphaFold 3 can map a vast universe of biomolecules

focus

Medicare says breakthrough device reimbursement rule to come by summer

STAT Summit: The economic case for universal basic health care

Apple Watch's A

First recipient of genetically engineered pig kidney has died

Readout LOUD podcast: Live from the 2023 STAT Summit

First recipient of genetically engineered pig kidney has died

hotspot

explore

focus

focus